Copyright © 2001 by the European Society of Cardiology.
Editorials
Dofetilide: what role in the treatment of ventricular tachyarrhythmias?
Centre Hospitalier Princesse Grace, Monaco
References
- Boriani G, Lubinski A, Capucci A. A multicentre, double blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J. 2001;22:21802191
[Abstract/Free Full Text] - Steinbeck G, Andresen D, Bach P. A comparison of electrophysiological1y guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N.Engl J Med. 1992;327:987992[Abstract]
- Mason JW. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med. 1993;329:445451
[Abstract/Free Full Text] - N Engl J Med. 1997;337:15761583
[Abstract/Free Full Text] - Connolly SJ, Hallstrom AP, Cappato R. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21:20712078
[Abstract/Free Full Text] - Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Identification of patients most likely to benefit from implantable cardioverter defibrillator therapy. Circulation. 2000;101:16601664
[Abstract/Free Full Text] - Domanski MJ, Saksena S, Epstein AE. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol. 1999;34:10901095
[Abstract/Free Full Text] - Ector H, Rickards F, Kappenberger L. The registry of the European Working Group on Cardiac Pacing. Europace. 2000;2:251255
[Free Full Text] - Saoudi, N, Yaici, K, Bergonzi, M, Bouzaar, B, Rinaldi, JP, Le défibrillateur: traitement d'exception: Une exception Française Cardiologie pratique, 2001
- Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993;329:452458
[Abstract/Free Full Text] - Carmeliet E. Voltage- and time-dependent block of the delayed K+current in cardiac myocytes by dofetilide. J Phamacol Exp The. 1992;262:809817
- Falk RH, Pollak A, Sinh SN, Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am. Coll. Cardiol. 1997;29:385390[Abstract]
- Bashir Y, Thomsen P-EB, Kingma JH. for the Dofetilide Arrhythmia Study Group. Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Am J Cardiol. 1995;76:10401044[CrossRef][Web of Science][Medline]
- Pedersen CT, Moller M, Bloch-Thomsen PE. for the Danish Investigations of Arrhythmia and Moratality on Dofetilide Study Group. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med. 1999;341:857865
[Abstract/Free Full Text] - Eur Heart J. 1989;10:685694
[Abstract/Free Full Text] - Julian DG, Prescott RJ, Jackson FS, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982;1:11421147[CrossRef][Web of Science][Medline]
- Pratt CM, Ruskin JN, Friedrich T. Dofetilide use in atrial fibrillation. A treatment staregy to minimize proarrhythmic risk (abstract). Journ Am Coll Cardiol. 2000;35:154A
- Pacifico A, Hohnloser S, Williams JH. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med. 1999;340:18551862
[Abstract/Free Full Text] - Kovoor P, Eipper V, Byth K, Cooper MJ, Uther JB, Ross DL. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease. Eur Heart J. 1999;20:364374
[Abstract/Free Full Text] - Mazur A, Anderson ME, Bonney S, Roden DM. Pause-dependent polymorphic ventricular tachycardia during long term treatment with dofetilide. J Am Coll Cardiol. 2001;37:11001105
[Abstract/Free Full Text] - Lauer MR. Dofetilide: is the treatment worse than the disease? J Am Coll Cardiol. 2001;37:11061110
[Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||